학술논문
The RA-BE-REAL Multinational, Prospective, Observational Study in Patients with Rheumatoid Arthritis Receiving Baricitinib, Targeted Synthetic, or Biologic Disease-Modifying Therapies: a 6-Month Interim Analysis
Document Type
Article
Author
Source
In: Rheumatology and Therapy . (Rheumatology and Therapy, February 2023, 10(1):73-93)
Subject
Language
English
ISSN
21986584
21986576
21986576